![]() ![]() According to the World Health organization, in the region of the Americas in 2019, chronic respiratory diseases account for: 534,242 deaths in both sexes, 267,516 (50%) deaths in men and 266,725 (50%) in women. Rise in prevalence of infectious respiratory disease is playing important role in the overall development of nasal vaccines market. Growing prevel ance of respiratory disease to foster market growth This trend is expected to continue in the near future due to to the ongoing advancement in the medical field and the growth of the global Nasal Vaccines market is projected to be high. Key Trends and Analysis of the Global Nasal Vaccines Market:įactors such as non-invasive and easy administration of nasal vaccines are contributing to the immense popularity of these vaccines. Moreover, growing demand for non-invasive vaccine delivery methods, and increasing government initiatives for vaccination programs are other factors boosting the growth of this market. Rising prevalence of respiratory infections, ongoing COVID-19 pandemic, and rise in research and development activities are major factor propelling growth of the nasal vaccines market. Nasal vaccines have emerged as a significant advancement in the field of vaccination, providing enhanced protection for both the vaccinated individuals and vulnerable members of the community.īurlingame, J(GLOBE NEWSWIRE) - Coherent Market Insights published a report, titled, “Nasal Vaccines Market, By Vaccine type (Live attenuated vaccines, Inactivated vaccines, Subunit, recombinant, and conjugate vaccines, Others (such as DNA vaccines, viral vector vaccines, etc.)), By Application (Influenza, COVID-19, Other respiratory infections (such as RSV, pneumococcal, etc., Others (such as cholera, typhoid, etc.)), By End user (Pediatrics, Adults, Geriatrics, Others (such as travelers, military personnel, etc.): Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030.” According to the nasal vaccines market is estimated to be valued at US$ 416.8 million in 2022 and is expected to exhibit a CAGR of 8.6 % during the forecast period (2022-2030).Īnalysts’ Views on Global Nasal Vaccines Market ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |